Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Clinical trial NCT00718809 · TERMINATED

Trial details

NCT number: NCT00718809
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Thymoma and Thymic Carcinoma Recurrent Thymoma and Thymic Carcinoma Stage III Thymoma Stage IVA Thymoma Stage IVB Thymoma

Start date: 2008-06-01
Primary completion: 2010-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.